Abstract
Introduction: Adenovirus-mediated herpes simplex virus thymidine kinase gene transfer in combination with ganciclovir (Ad-TK/GCV) is one of the major gene therapy strategies to eradicate tumor cells. Leiomyoma is a benign uterine tumor that affects high percentage of women in their reproductive age. Unfortunately, there is no effective and safe medical treatment available. Leiomyom is developed as discrete well-defined tumor, easily accessible with imaging techniques which makes it a good candidate for localized gene therapy approaches.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
